Advertisement

Cellular Engineering and Cellular Therapies — An Overview

  • L. F. M. H. de Leij
  • M. J. A. van Luyn
  • M. C. Harmsen
Conference paper
Part of the Developments in Hematology and Immunology book series (DIHI, volume 38)

Abstract

Cellular therapy offers a challenging approach for the treatment of a variety of diseases. Although some types of cellular therapy, like the generation and application of appropriately differentiated embryonic or adult stem cells, still await the successful outcome of a lot of further experiments, others have been established and clinically applied already a long time ago. So, a lot of clinical experience has been obtained with both autologous and allogeneic bone marrow transplantation protocols and various kinds of immunotherapeutical approaches employing ex vivo activated and cultured NK cells, cytotoxic T lymphocytes or dendritic cells. These trials have shown that cellular therapy can be given in a safe and controlled way. The current Good Manufacturing Practice (cGMP) procedures already established for the preparation, culturing and ex vivo manipulation of cells in these types of applications should be taken into account in implementing appropriate policies and procedures leading to cGMP procedures for future types of cellular therapy such as the use of manipulated stem cells.

Keywords

Stem Cell Embryonic Stem Cell Adult Stem Cell Cellular Therapy Bone Marrow Derive Stem Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Paul G, Li J-Y, Brundin P. Stem cells: hype or hope? Drug Discovery Today 2002;7:295–302.PubMedCrossRefGoogle Scholar
  2. 2.
    Alison MR, Poulsom R, Jeffery R, et al. Cell differentiation: Hepatocytes from non-hepatic adult stem cells. Nature 2000;406:257.PubMedCrossRefGoogle Scholar
  3. 3.
    Lindvall, O and Hagell, P. Clinical observations after neural transplantation in Parkinson’s disease. Prog Brain Res. 2000;127:299–320.PubMedCrossRefGoogle Scholar
  4. 4.
    Rolletschek A, Chang H, Guan K, Czyz J, Meyer M, Wobus AM. Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors. Mech Dev 2001;105:93–104.PubMedCrossRefGoogle Scholar
  5. 5.
    Lee, SH, Lumelsky, N, Auerbach, JM, McKay, RD. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nature Biotechnol 2002;18:675–79.CrossRefGoogle Scholar
  6. 6.
    Kim J-H, Auerbach JM, Rodriguez-Gomez JA, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson’s disease. Nature 2002;418:50–56.PubMedCrossRefGoogle Scholar
  7. 7.
    Björklund LM, Sánchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci 2002;99:2344–49.PubMedCrossRefGoogle Scholar
  8. 8.
    Reubinoff BE, Itsykson P, Turetsky T, et al. Neural progenitors from human embryonic stem cells. Nat Biotechnol 2001; 19:1134–40.PubMedCrossRefGoogle Scholar
  9. 9.
    Bonner-Weir S, Taneja M, Weir G. C, et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci 2002;97:7999–8004.CrossRefGoogle Scholar
  10. 10.
    Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of Embryonic Stem Cells to Insulin-Secreting Structures Similar to Pancreatic Islets. Science 2001;292:1389–94.PubMedCrossRefGoogle Scholar
  11. 11.
    Horb ME, Shen C-N, Tosh D, Slack JMW. Experimental conversion of liver to pancreas. Curr. Biol 20 J Clin Invest 2003;108:407–14.Google Scholar
  12. 12.
    Kehat I, Kenyagin-Karsenti D, Snir M. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of car-diomyocytes. J Clin Invest 2001;108: 407–14.PubMedGoogle Scholar
  13. 13.
    Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infracted myocardium. Nature 2001;410:701–05.PubMedCrossRefGoogle Scholar
  14. 14.
    van Luyn, MJ, Tio RA, Gallego Y, et al. Cadiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures. Biomaterials 2002;23:4793–801.PubMedCrossRefGoogle Scholar
  15. 15.
    Reyes M, Lund T, Lenvic T, Aguiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001;98:2615–25.PubMedCrossRefGoogle Scholar
  16. 16.
    Jiang Y, Vaessen B, Lenvic T, Blackstad M, Reyes M, Verfaillie CM. Multipotent progenitor cells can be isolated from postnatal murine bone marror, muscle, and brain. Exp Hematol 2001;30:896–904.CrossRefGoogle Scholar
  17. 17.
    Stem cells: Scientific Progress and Future Research Directions. Report by the Department of Health and Human Services. June 2001.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2003

Authors and Affiliations

  • L. F. M. H. de Leij
  • M. J. A. van Luyn
  • M. C. Harmsen
    • 1
  1. 1.Department of Pathology and Laboratory Medicine, Medical Biology sectionUniversity Medical Centre GroningenGroningenThe Netherlands

Personalised recommendations